Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment
BackgroundThe risk factors of papillary thyroid carcinoma (PTC) recurrence are meaningful for patients and clinicians. Tumor mutation burden (TMB) has been a biomarker for the effectiveness of immune checkpoint inhibitor (ICI) and prognosis in cancer. However, the role of TMB and its latent signific...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2021-06-01
|
| Colección: | Frontiers in Endocrinology |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fendo.2021.674616/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|